Vivo Capital VIII, LLC Insider Trading $CRNX Crinetics Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Vivo Capital VIII, LLC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Vivo Capital VIII, LLC. Vivo Capital VIII, LLC is 10% Owner in IMPEL NEUROPHARMA INC ($IMPL) and 10% Owner in BioPharmX Corp ($TPND) and 10% Owner in Menlo Therapeutics, Inc. ($MNLO) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Nabriva Therapeutics plc ($NBRV) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).

Vivo Capital VIII, LLC in Crinetics Pharmaceuticals, Inc.

Trading Symbol: CRNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vivo Capital VIII, LLC: 10% Owner
Holdings: 2,263,447 shares
Latest Transaction: Apr 17 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Vivo Capital VIII, LLC in Crinetics Pharmaceuticals, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALGS, BOLT, CRNX, IMPL, NBRV, TERN, TMBR, MNLO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 17 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS15.4010,265158,081298,625308.9 K to 298.6 K (-3.32 %)
Apr 17 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS15.4074,3331,144,7282,162,5872.2 M to 2.2 M (-3.32 %)
Apr 17 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS15.203,66355,678308,890312.6 K to 308.9 K (-1.17 %)
Apr 17 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS15.2026,527403,2102,236,9202.3 M to 2.2 M (-1.17 %)
Apr 17 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS15.5026,185405,868312,553338.7 K to 312.6 K (-7.73 %)
Apr 17 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS15.50189,6252,939,1882,263,4472.5 M to 2.3 M (-7.73 %)
Apr 07 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS14.2074210,536338,738339.5 K to 338.7 K (-0.22 %)
Apr 07 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS14.205,37376,2972,453,0722.5 M to 2.5 M (-0.22 %)
Apr 07 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS13.8036,400502,320339,480375.9 K to 339.5 K (-9.68 %)
Apr 07 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS13.80263,6003,637,6802,458,4452.7 M to 2.5 M (-9.68 %)
Mar 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS19.501332,594168,165168.3 K to 168.2 K (-0.08 %)
Mar 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS19.5048936375,880375.9 K to 375.9 K (-0.01 %)
Mar 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS19.503476,7672,722,0452.7 M to 2.7 M (-0.01 %)
Feb 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS21.405,904126,346168,298174.2 K to 168.3 K (-3.39 %)
Feb 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS21.402004,280375,928376.1 K to 375.9 K (-0.05 %)
Feb 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS21.401,45131,0512,722,3922.7 M to 2.7 M (-0.05 %)
Feb 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.004,614101,508174,202178.8 K to 174.2 K (-2.58 %)
Feb 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.001573,454376,128376.3 K to 376.1 K (-0.04 %)
Feb 11 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.001,13424,9482,723,8432.7 M to 2.7 M (-0.04 %)
Feb 06 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.8010,519239,833178,816189.3 K to 178.8 K (-5.56 %)
Feb 06 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.803578,140376,285376.6 K to 376.3 K (-0.09 %)
Feb 06 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.802,58458,9152,724,9772.7 M to 2.7 M (-0.09 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS21.704,22091,574189,335193.6 K to 189.3 K (-2.18 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS21.701433,103376,642376.8 K to 376.6 K (-0.04 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS21.701,03722,5032,727,5612.7 M to 2.7 M (-0.04 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.105,940131,274193,555199.5 K to 193.6 K (-2.98 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.102014,442376,785377 K to 376.8 K (-0.05 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.101,45932,2442,728,5982.7 M to 2.7 M (-0.05 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.2010,878241,492199,495210.4 K to 199.5 K (-5.17 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.203698,192376,986377.4 K to 377 K (-0.10 %)
Jan 31 2020CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.202,67359,3412,730,0572.7 M to 2.7 M (-0.10 %)
Mar 25 2019CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.2583,9841,868,644210,373294.4 K to 210.4 K (-28.53 %)
Mar 25 2019CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.2540,407899,056377,355417.8 K to 377.4 K (-9.67 %)
Mar 25 2019CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerSellS22.25292,6096,510,5502,732,7303 M to 2.7 M (-9.67 %)
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.00187,64800
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.001,358,90300
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.001,163,31100
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerOption ExerciseC0.008,424,41600
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyP20.73153,1803,175,421294,357141.2 K to 294.4 K (+108.50 %)
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyP17.00141,1772,400,009141,1770 to 141.2 K
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyP17.007,137121,329417,762410.6 K to 417.8 K (+1.74 %)
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyP17.0051,686878,6623,025,3393 M to 3 M (+1.74 %)
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyC0.0057,0350410,625353.6 K to 410.6 K (+16.13 %)
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyC0.00413,04002,973,6532.6 M to 3 M (+16.13 %)
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyC0.00353,5900353,5900 to 353.6 K
Jul 20 2018CRNXCrinetics Pharmace ...Vivo Capital VIII, LLC10% OwnerBuyC0.002,560,61302,560,6130 to 2.6 M

Page:   1